• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾上腺偶发瘤是否具有功能活性?基于患者的评估方法综述。

Is the Adrenal Incidentaloma Functionally Active? An Approach-To-The-Patient-Based Review.

作者信息

Bernardi Stella, Calabrò Veronica, Cavallaro Marco, Lovriha Sara, Eramo Rita, Fabris Bruno, de Manzini Nicolò, Dobrinja Chiara

机构信息

Department of Medical, Surgical and Health Sciences, University of Trieste, Strada di Fiume 447, 34149 Trieste, Italy.

SS Endocrinologia, UCO Medicina Clinica, ASUGI (Azienda Sanitaria Universitaria Giuliano Isontina), Cattinara Teaching Hospital, Strada di Fiume 447, 34149 Trieste, Italy.

出版信息

J Clin Med. 2022 Jul 14;11(14):4064. doi: 10.3390/jcm11144064.

DOI:10.3390/jcm11144064
PMID:35887828
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9323753/
Abstract

Adrenal incidentalomas are a common occurrence. Most of them are adrenocortical adenomas that do not cause harm and do not require surgery, but a non-negligible proportion of incidentalomas is represented by functionally active masses, including cortisol-secreting adenomas (12%), pheochromocytomas (3-6%), aldosterone-secreting adenomas (2-3%), as well as malignant nodules, such as adrenocortical carcinomas (2-5%), which can be either functioning or non-functioning. All patients with an adrenal incidentaloma should undergo a few biochemical screening and confirmatory tests to exclude the presence of a functionally active mass. In this approach-to-the-patient-based review, we will summarize current recommendations on biochemical evaluation and management of functionally active adrenal incidentalomas. For this purpose, we will present four case vignettes, whereby we will describe how patients were managed, then we will review and discuss additional considerations tied to the diagnostic approach, and conclude with practical aspects of patient perioperative management. To improve the perioperative management of patients with functional adrenal incidentalomas, multidisciplinary meetings are advocated.

摘要

肾上腺偶发瘤很常见。其中大多数是肾上腺皮质腺瘤,不会造成危害,也不需要手术,但仍有不可忽视比例的偶发瘤为功能活跃性肿块,包括分泌皮质醇的腺瘤(12%)、嗜铬细胞瘤(3% - 6%)、分泌醛固酮的腺瘤(2% - 3%),以及恶性结节,如肾上腺皮质癌(2% - 5%),这些肿瘤可能是功能性的,也可能是非功能性的。所有肾上腺偶发瘤患者都应接受一些生化筛查和确诊检查,以排除功能活跃性肿块的存在。在这篇基于患者诊疗过程的综述中,我们将总结目前关于功能活跃性肾上腺偶发瘤生化评估和管理的建议。为此,我们将展示四个病例 vignettes,描述患者的诊疗过程,然后回顾和讨论与诊断方法相关的其他注意事项,并以患者围手术期管理的实际问题作为总结。为改善功能活跃性肾上腺偶发瘤患者的围手术期管理,提倡多学科会诊。 (注:原文中“vignettes”未找到完全准确对应中文词汇,暂保留英文)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53c/9323753/269d863ae66e/jcm-11-04064-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53c/9323753/269d863ae66e/jcm-11-04064-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c53c/9323753/269d863ae66e/jcm-11-04064-g001.jpg

相似文献

1
Is the Adrenal Incidentaloma Functionally Active? An Approach-To-The-Patient-Based Review.肾上腺偶发瘤是否具有功能活性?基于患者的评估方法综述。
J Clin Med. 2022 Jul 14;11(14):4064. doi: 10.3390/jcm11144064.
2
Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group.肾上腺偶发瘤:来自意大利国家研究小组的激素数据概述
Horm Res. 1997;47(4-6):284-9. doi: 10.1159/000185478.
3
Diagnostic efficacy of 18F-FDG PET/CT in patients with adrenal incidentaloma.18F-FDG PET/CT对肾上腺偶发瘤患者的诊断效能
Endocr Connect. 2019 Jul;8(7):838-845. doi: 10.1530/EC-19-0204.
4
Management of adrenal incidentaloma.肾上腺偶发瘤的管理
Best Pract Res Clin Endocrinol Metab. 2009 Apr;23(2):233-43. doi: 10.1016/j.beem.2009.04.001.
5
Outcome in patients with adrenal incidentaloma selected for surgery: an analysis of 88 cases investigated in a single clinical center.因肾上腺偶发瘤而接受手术的患者的治疗结果:对在单一临床中心研究的88例病例的分析
Eur J Endocrinol. 2000 Jul;143(1):111-7. doi: 10.1530/eje.0.1430111.
6
NIH state-of-the-science statement on management of the clinically inapparent adrenal mass ("incidentaloma").美国国立卫生研究院关于临床无症状肾上腺肿块(“偶发瘤”)管理的科学现状声明。
NIH Consens State Sci Statements. 2002;19(2):1-25.
7
Adrenalectomy for incidentaloma: lessons learned from a single-centre series of 274 patients.肾上腺意外瘤的肾上腺切除术:来自单中心274例患者系列的经验教训。
ANZ J Surg. 2018 May;88(5):468-473. doi: 10.1111/ans.14095. Epub 2017 Jul 7.
8
A nationwide survey of adrenal incidentalomas in Japan: the first report of clinical and epidemiological features.日本全国性的肾上腺意外瘤调查:临床和流行病学特征的首次报告。
Endocr J. 2020 Feb 28;67(2):141-152. doi: 10.1507/endocrj.EJ18-0486. Epub 2019 Nov 7.
9
A multidisciplinary approach to the management of adrenal incidentaloma.肾上腺偶发瘤管理的多学科方法。
Expert Rev Endocrinol Metab. 2021 Jul;16(4):201-212. doi: 10.1080/17446651.2021.1948327. Epub 2021 Jul 9.
10
Investigation and assessment of adrenal incidentalomas.肾上腺意外瘤的调查与评估。
Clin Med (Lond). 2023 Mar;23(2):135-140. doi: 10.7861/clinmed.2023-0042.

引用本文的文献

1
A novel germline (c.314T>A) variant in metastatic paraganglioma: case report and literature review.转移性副神经节瘤中的一种新型种系(c.314T>A)变异:病例报告及文献综述
Front Endocrinol (Lausanne). 2025 Mar 27;16:1577421. doi: 10.3389/fendo.2025.1577421. eCollection 2025.
2
Association Between Thyrotoxicosis and Cerebral Venous Thrombosis.甲状腺毒症与脑静脉血栓形成之间的关联。
J Clin Med. 2024 Oct 31;13(21):6547. doi: 10.3390/jcm13216547.
3
Who and how to screen for endogenous hypercortisolism in adrenal and pituitary incidentaloma.

本文引用的文献

1
Predictors of Tumour Growth and Autonomous Cortisol Secretion Development during Follow-Up in Non-Functioning Adrenal Incidentalomas.非功能性肾上腺偶发瘤随访期间肿瘤生长及自主性皮质醇分泌发展的预测因素
J Clin Med. 2021 Nov 25;10(23):5509. doi: 10.3390/jcm10235509.
2
ACR Appropriateness Criteria® Adrenal Mass Evaluation: 2021 Update.ACR 适宜性标准®肾上腺肿块评估:2021 更新版。
J Am Coll Radiol. 2021 Nov;18(11S):S251-S267. doi: 10.1016/j.jacr.2021.08.010.
3
Incidental Adrenal Masses: Adherence to Guidelines and Methods to Improve Initial Follow-Up: A Systematic Review.
谁以及如何筛查肾上腺和垂体偶发瘤中的内源性皮质醇增多症。
J Endocrinol Invest. 2025 Apr;48(Suppl 1):63-71. doi: 10.1007/s40618-024-02456-6. Epub 2024 Oct 12.
4
Adrenal Referral Pattern: Management of Patients With an Adrenal Incidentaloma.肾上腺转诊模式:肾上腺意外瘤患者的处理。
J Surg Res. 2024 Oct;302:144-149. doi: 10.1016/j.jss.2024.07.051. Epub 2024 Aug 2.
5
For small (1-3cm) nonfunctional adrenal incidentaloma (NFAI), which option is more appropriate for conservative treatment or surgery?对于直径小于 3cm 的无功能性肾上腺意外瘤(NFAI),哪种治疗方案更适合保守治疗还是手术治疗?
Front Endocrinol (Lausanne). 2023 Feb 1;14:1119251. doi: 10.3389/fendo.2023.1119251. eCollection 2023.
6
The Entity of Connshing Syndrome: Primary Aldosteronism with Autonomous Cortisol Secretion.康欣综合征的实体:原发性醛固酮增多症伴自主性皮质醇分泌。
Diagnostics (Basel). 2022 Nov 13;12(11):2772. doi: 10.3390/diagnostics12112772.
偶发性肾上腺肿块:遵循指南及改善初始随访的方法:一项系统综述
J Surg Res. 2022 Jan;269:18-27. doi: 10.1016/j.jss.2021.07.041. Epub 2021 Sep 8.
4
Surgical Management of Adrenocortical Carcinoma: Current Highlights.肾上腺皮质癌的外科治疗:当前要点
Biomedicines. 2021 Jul 28;9(8):909. doi: 10.3390/biomedicines9080909.
5
Surgical outcomes in the pheochromocytoma surgery. Results from the PHEO-RISK STUDY.pheochromocytoma 手术的外科治疗结果。来自 PHEO-RISK 研究的结果。
Endocrine. 2021 Dec;74(3):676-684. doi: 10.1007/s12020-021-02843-6. Epub 2021 Aug 9.
6
A multidisciplinary approach to the management of adrenal incidentaloma.肾上腺偶发瘤管理的多学科方法。
Expert Rev Endocrinol Metab. 2021 Jul;16(4):201-212. doi: 10.1080/17446651.2021.1948327. Epub 2021 Jul 9.
7
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism.2020年意大利动脉高血压学会(SIIA)原发性醛固酮增多症管理实用指南。
Int J Cardiol Hypertens. 2020 Apr 15;5:100029. doi: 10.1016/j.ijchy.2020.100029. eCollection 2020 Jun.
8
Approach to the Patient with Primary Aldosteronism: Utility and Limitations of Adrenal Vein Sampling.原发性醛固酮增多症患者的处理方法:肾上腺静脉采样的效用和局限性。
J Clin Endocrinol Metab. 2021 Mar 25;106(4):1195-1208. doi: 10.1210/clinem/dgaa952.
9
Genotype-Phenotype Features of Germline Variants of the TMEM127 Pheochromocytoma Susceptibility Gene: A 10-Year Update.TMEM127 嗜铬细胞瘤易感性基因种系变异的表型-基因型特征:10 年更新。
J Clin Endocrinol Metab. 2021 Jan 1;106(1):e350-e364. doi: 10.1210/clinem/dgaa741.
10
The impact of adrenal tumor multidisciplinary team meetings on clinical outcomes.肾上腺肿瘤多学科团队会议对临床结局的影响。
Endocrine. 2020 Sep;69(3):519-525. doi: 10.1007/s12020-020-02361-x. Epub 2020 Jul 23.